Pharmacists in Long Branch, New Jersey


14 Pharmacists found in Long Branch
male pharmacist

Amit Sheth


Pharmacist
186 Broadway, Long Branch, NJ 07740
732-222-1481     732-870-0603

male pharmacist

Andrew I Silver, RPH


Pharmacist
205 Morris Ave, Long Branch, NJ 07740
732-222-6400    

female pharmacist

Christin Asaad


Pharmacist
205 Morris Ave, Long Branch, NJ 07740
732-222-6200    



female pharmacist

Cynthia Laracuente, PHARM D.


Pharmacist
300 2nd Ave, Long Branch, NJ 07740
732-923-6111     732-923-6115

female pharmacist

Emma Ngoc Nguyen, PHARMD


Pharmacist
71 S Broadway, Long Branch, NJ 07740
732-222-8027    

male pharmacist

Dr. George E Gdovin, PHARMD


Pharmacist
71 S Broadway, Long Branch, NJ 07740
732-222-8027    

female pharmacist

Germin Fahim, PHARMD, BCPS


Pharmacist
300 2nd Ave, Long Branch, NJ 07740
732-923-5000    

male pharmacist

Mr. Hany Haddad, RPH


Pharmacist
71 S Broadway, Long Branch, NJ 07740
732-222-8027    

male pharmacist

Mr. Harold Russell Jones


Pharmacist
601 Broadway, Long Branch, NJ 07740
732-222-5400    

female pharmacist

Heenaben Patel


Pharmacist
197 Norwood Ave, Long Branch, NJ 07740
732-245-5937    

male pharmacist

Mr. John F. Karpus, R.PH.


Pharmacist
205 Morris Ave, Long Branch, NJ 07740
732-222-6400    

male pharmacist

Kevin Chen


Pharmacist - Psychiatric
300 2nd Ave, Long Branch, NJ 07740
732-923-6307    

male pharmacist

Dr. Samuel Paul Golbin, PHARMD


Pharmacist
300 2nd Ave, Long Branch, NJ 07740
732-923-7935    

female pharmacist

Ms. Sofia Berardi


Pharmacist
71 S Broadway, Long Branch, NJ 07740
732-222-8027    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.